Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (331-340 of 574) with videos related to

Pageof 58
Sort By:
Oncotarget|September 17, 2017
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib <i>versus</i> chemotherapy in advanced non-small cell lung cancer patientsLucia Kim, Mauro Saieg, Massimo Di Maio, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2017
Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancerMark K Doherty, Grzegorz J Korpanty, Pascale Tomasini, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse eventsPooja Middha, Rohit Thummalapalli, Zoe Quandt, et al.
Carcinogenesis|May 25, 2011
Genetic associations with sporadic neuroendocrine tumor riskMonica Ter-Minassian, Zhaoxi Wang, Kofi Asomaning, et al.
Clinical Lung Cancer|October 21, 2022
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung CancerSabine Schmid, Sierra Cheng, Simren Chotai, et al.
Lung Cancer (Amsterdam, Netherlands)|March 17, 2021
A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?"Geoffrey Liu, Hermann Brenner, Chu Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 25, 2020
Health-related social media use and preferences of adolescent and young adult cancer patients for virtual programmingReenika Aggarwal, Katrina Hueniken, Lawson Eng, et al.
Journal of Epidemiology and Global Health|October 27, 2023
A Population-Based Outcome-Wide Association Study of the Comorbidities and Sequelae Following COVID-19 InfectionYuyang Zhang, Junhong Li, Lan Feng, et al.
Cancer Medicine|October 16, 2018
Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancerDaniel Shepshelovich, Amanda R Townsend, Osvaldo Espin-Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Second-hand smoke as a predictor of smoking cessation among lung cancer survivorsLawson Eng, Jie Su, Xin Qiu, et al.
Pageof 58

Showing results (331-340 of 574) with videos related to

Sort By:
Pageof 58
Oncotarget|September 17, 2017
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib <i>versus</i> chemotherapy in advanced non-small cell lung cancer patientsLucia Kim, Mauro Saieg, Massimo Di Maio, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2017
Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancerMark K Doherty, Grzegorz J Korpanty, Pascale Tomasini, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse eventsPooja Middha, Rohit Thummalapalli, Zoe Quandt, et al.
Carcinogenesis|May 25, 2011
Genetic associations with sporadic neuroendocrine tumor riskMonica Ter-Minassian, Zhaoxi Wang, Kofi Asomaning, et al.
Clinical Lung Cancer|October 21, 2022
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung CancerSabine Schmid, Sierra Cheng, Simren Chotai, et al.
Lung Cancer (Amsterdam, Netherlands)|March 17, 2021
A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?"Geoffrey Liu, Hermann Brenner, Chu Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 25, 2020
Health-related social media use and preferences of adolescent and young adult cancer patients for virtual programmingReenika Aggarwal, Katrina Hueniken, Lawson Eng, et al.
Journal of Epidemiology and Global Health|October 27, 2023
A Population-Based Outcome-Wide Association Study of the Comorbidities and Sequelae Following COVID-19 InfectionYuyang Zhang, Junhong Li, Lan Feng, et al.
Cancer Medicine|October 16, 2018
Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancerDaniel Shepshelovich, Amanda R Townsend, Osvaldo Espin-Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Second-hand smoke as a predictor of smoking cessation among lung cancer survivorsLawson Eng, Jie Su, Xin Qiu, et al.
Pageof 58